Article Information
History
- July 12, 2024.
Article Versions
- You are currently viewing Version 1 of this article (July 12, 2024 - 09:54).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Chaoyang Liang1,†,
- Qi Song2,†,
- Wenhao Zhou3,†,
- Na Li3,†,
- Qi Xiong2,
- Chaohu Pan3,
- Shaohong Zhao4,
- Xiang Yan2,
- Xiaoling Zhang2,
- Yaping Long5,
- Juntang Guo1,
- Tao Wang1,
- Weiwei Shi2,
- Shengjie Sun2,
- Bo Yang1,
- Zhouhuan Dong6,
- Haitao Luo3,*,
- Jie Li6,*,
- Yi Hu2,* and
- Bo Yang2,*
- 1Department of Thoracic Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, China
- 2Department of Oncology, Chinese PLA General Hospital, Beijing, China
- 3Shenzhen Engineering Center for Translational Medicine of Precision Cancer Immunodiagnosis and Therapy, YuceBio Technology Co., Ltd, Shenzhen, China
- 4Department of Radiology, the First Medical Center, Chinese PLA General Hospital, Beijing, China
- 5School of Medicine, Nankai University, Tianjin, China
- 6Department of Pathology, the First Medical Center, Chinese PLA General Hospital, Beijing, China
- ↵*Correspondence: Bo Yang: yangbo{at}301hospital.com.cn Yi Hu: huyi{at}301hosptial.com.cn, Jie Li: lijiek812{at}301hospital.com.cn Haitao Luo: luohhaitao{at}yucebio.com
↵† Chaoyang Liang, Qi Song, Wenhao Zhou, and Na Li contributed equally to this work.
Posted July 12, 2024.
Low-dose chemotherapy combined with delayed immunotherapy in the neoadjuvant treatment of non-small cell lung cancer and dynamic monitoring of the drug response in peripheral blood
